RYBREVANT 1600 MG SOLUCION INYECTABLE
RYBREVANT 1600 MG SOLUCION INYECTABLE
Pending
Register Number
1211594002
Prescription Type
Uso Hospitalario
Authorization Date
Apr 14, 2025
Dosage Form
SOLUCIÓN INYECTABLE
Route: VÍA SUBCUTÁNEA
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number1211594002
EMA Approved
Yes
Drug Classification
✗
Generic
No
✗
Orphan
No
✗
Biosimilar
No
✗
Commercialized
No
CIMA AEMPS Classification
INGREDIENTS (1)
AMIVANTAMABActive
Quantity: 1600 mg
Name: AMIVANTAMAB
ATC CLASSIFICATION (3)
L01F
L01FX
L01FX18